Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 349

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 349
---
 |   |     |      |           — |   |
| Changes in fair value measurements  |     |                             |           — |   |     |      |   (347,093 | ) |     |                           |           — |   |     |      |  (4,176,001 | ) |
| Interest income (expense), net      |     |                             |      65,062 |   |     |      | (1,315,418 | ) |     |                           |     109,819 |   |     |      |  (1,557,898 | ) |
| Total Other (Expense) Income        |     |                             |   1,195,607 |   |     |      | (1,662,511 | ) |     |                           |   1,992,918 |   |     |      |  (5,733,899 | ) |
| Net Loss                            |     |                           $ | (12,367,376 | ) |     |    $ | (7,869,235 | ) |     |                         $ | (20,606,193 | ) |     |    $ | (22,952,377 | ) |

F-104

**Note 5-Netloss per share**

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:

| Numerator:                                                                 |     | Three months ended June 30 
 2025                       |            |   |     | 2024 |            |   |     | Six months ended June 30 
 2025                     |             |   |     | 2024 |             |   |
|:---------------------------------------------------------------------------|:----|:---------------------------|-----------:|:--|:----|:-----|-----------:|:--|:----|:-------------------------|------------:|:--|:----|:-----|------------:|:--|
| Net loss attributable to common stockholders                               |     | $                          | (9,525,924 | ) |     | $    | (5,265,235 | ) |     | $                        | (16,192,384 | ) |     | $    | (10,107,377 | ) |
| Denominator:                                                               |     |                            |            |   |     |      |            |   |     |                          |             |   |     |      |             |   |
| Weighted-average common shares outstanding - basic and diluted